These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

341 related articles for article (PubMed ID: 19417147)

  • 1. Targeting the cancer stroma with a fibroblast activation protein-activated promelittin protoxin.
    LeBeau AM; Brennen WN; Aggarwal S; Denmeade SR
    Mol Cancer Ther; 2009 May; 8(5):1378-86. PubMed ID: 19417147
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting carcinoma-associated fibroblasts within the tumor stroma with a fibroblast activation protein-activated prodrug.
    Brennen WN; Rosen DM; Wang H; Isaacs JT; Denmeade SR
    J Natl Cancer Inst; 2012 Sep; 104(17):1320-34. PubMed ID: 22911669
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selective Activation of Anticancer Chemotherapy by Cancer-Associated Fibroblasts in the Tumor Microenvironment.
    Kim MG; Shon Y; Kim J; Oh YK
    J Natl Cancer Inst; 2017 Jan; 109(1):. PubMed ID: 27615014
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Iterative design of emetine-based prodrug targeting fibroblast activation protein (FAP) and dipeptidyl peptidase IV DPPIV using a tandem enzymatic activation strategy.
    Akinboye ES; Brennen WN; Rosen DM; Bakare O; Denmeade SR
    Prostate; 2016 Jun; 76(8):703-14. PubMed ID: 26835873
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fibroblast activation protein-α promotes tumor growth and invasion of breast cancer cells through non-enzymatic functions.
    Huang Y; Simms AE; Mazur A; Wang S; León NR; Jones B; Aziz N; Kelly T
    Clin Exp Metastasis; 2011 Aug; 28(6):567-79. PubMed ID: 21604185
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting inhibition of fibroblast activation protein-α and prolyl oligopeptidase activities on cells common to metastatic tumor microenvironments.
    Christiansen VJ; Jackson KW; Lee KN; Downs TD; McKee PA
    Neoplasia; 2013 Apr; 15(4):348-58. PubMed ID: 23555181
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [FIBROBLAST ACTIVATION PROTEIN (FAP) AS A POSSIBLE TARGET OF THE ANTITUMOR STRATEGY.].
    Pleshkan VV; Alekseenko IV; Tyulkina DV; Kyzmich AI; Zinovyeva MV; Sverdlov ED
    Mol Gen Mikrobiol Virusol; 2016; 34(3):90-97. PubMed ID: 30383930
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fibroblast activation protein regulates tumor-associated fibroblasts and epithelial ovarian cancer cells.
    Lai D; Ma L; Wang F
    Int J Oncol; 2012 Aug; 41(2):541-50. PubMed ID: 22614695
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fibroblast activation protein-α in fibrogenic disorders and cancer: more than a prolyl-specific peptidase?
    Juillerat-Jeanneret L; Tafelmeyer P; Golshayan D
    Expert Opin Ther Targets; 2017 Oct; 21(10):977-991. PubMed ID: 28829211
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular cloning of fibroblast activation protein alpha, a member of the serine protease family selectively expressed in stromal fibroblasts of epithelial cancers.
    Scanlan MJ; Raj BK; Calvo B; Garin-Chesa P; Sanz-Moncasi MP; Healey JH; Old LJ; Rettig WJ
    Proc Natl Acad Sci U S A; 1994 Jun; 91(12):5657-61. PubMed ID: 7911242
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fibroblast activation protein alpha is expressed by transformed and stromal cells and is associated with mesenchymal features in glioblastoma.
    Busek P; Balaziova E; Matrasova I; Hilser M; Tomas R; Syrucek M; Zemanova Z; Krepela E; Belacek J; Sedo A
    Tumour Biol; 2016 Oct; 37(10):13961-13971. PubMed ID: 27492457
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antitumor effects of chimeric receptor engineered human T cells directed to tumor stroma.
    Kakarla S; Chow KK; Mata M; Shaffer DR; Song XT; Wu MF; Liu H; Wang LL; Rowley DR; Pfizenmaier K; Gottschalk S
    Mol Ther; 2013 Aug; 21(8):1611-20. PubMed ID: 23732988
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Suppression of tumor growth in mice by rationally designed pseudopeptide inhibitors of fibroblast activation protein and prolyl oligopeptidase.
    Jackson KW; Christiansen VJ; Yadav VR; Silasi-Mansat R; Lupu F; Awasthi V; Zhang RR; McKee PA
    Neoplasia; 2015 Jan; 17(1):43-54. PubMed ID: 25622898
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of Novel Natural Substrates of Fibroblast Activation Protein-alpha by Differential Degradomics and Proteomics.
    Zhang HE; Hamson EJ; Koczorowska MM; Tholen S; Chowdhury S; Bailey CG; Lay AJ; Twigg SM; Lee Q; Roediger B; Biniossek ML; O'Rourke MB; McCaughan GW; Keane FM; Schilling O; Gorrell MD
    Mol Cell Proteomics; 2019 Jan; 18(1):65-85. PubMed ID: 30257879
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics and toxicology of a fibroblast activation protein (FAP)-activated prodrug in murine xenograft models of human cancer.
    Brennen WN; Rosen DM; Chaux A; Netto GJ; Isaacs JT; Denmeade SR
    Prostate; 2014 Sep; 74(13):1308-19. PubMed ID: 25053236
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A rare variant in human fibroblast activation protein associated with ER stress, loss of enzymatic function and loss of cell surface localisation.
    Osborne B; Yao TW; Wang XM; Chen Y; Kotan LD; Nadvi NA; Herdem M; McCaughan GW; Allen JD; Yu DM; Topaloglu AK; Gorrell MD
    Biochim Biophys Acta; 2014 Jul; 1844(7):1248-59. PubMed ID: 24717288
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Specific inhibition of fibroblast activation protein (FAP)-alpha prevents tumor progression in vitro.
    Teichgräber V; Monasterio C; Chaitanya K; Boger R; Gordon K; Dieterle T; Jäger D; Bauer S
    Adv Med Sci; 2015 Sep; 60(2):264-72. PubMed ID: 26057860
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased expression of fibroblast activation protein-alpha in keloid fibroblasts: implications for development of a novel treatment option.
    Dienus K; Bayat A; Gilmore BF; Seifert O
    Arch Dermatol Res; 2010 Dec; 302(10):725-31. PubMed ID: 20872224
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting fibroblast activation protein in cancer - Prospects and caveats.
    Busek P; Mateu R; Zubal M; Kotackova L; Sedo A
    Front Biosci (Landmark Ed); 2018 Jun; 23(10):1933-1968. PubMed ID: 29772538
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Theranostics Targeting Fibroblast Activation Protein in the Tumor Stroma:
    Watabe T; Liu Y; Kaneda-Nakashima K; Shirakami Y; Lindner T; Ooe K; Toyoshima A; Nagata K; Shimosegawa E; Haberkorn U; Kratochwil C; Shinohara A; Giesel F; Hatazawa J
    J Nucl Med; 2020 Apr; 61(4):563-569. PubMed ID: 31586001
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.